Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 9 - Drugs for disorders of the cardiovascular system
Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484)
09/2000
09/28/2000CA2365247A1 49 human secreted proteins
09/28/2000CA2365243A1 Human transmembrane proteins
09/28/2000CA2365238A1 48 human secreted proteins
09/28/2000CA2365223A1 46 human secreted proteins
09/28/2000CA2365104A1 Anti-p53 antibodies
09/28/2000CA2362700A1 Tricyclic indole-2-carboxylic acid compound used as nmda receptor antagonist
09/27/2000EP1038872A1 4-Phenyl-4-heteroarylpiperdine derivatives as opioid receptor ligands
09/27/2000EP1038863A2 Substituted dimeric compounds, process for their preparation and pharmaceutical compositions thereof
09/27/2000EP1038011A2 Methods of producing anti-angiogenic proteins; endostatin, angiostatin or restin, using a pichia yeast expression system
09/27/2000EP1037994A1 Peptide antagonists of vascular endothelial growth factor
09/27/2000EP1037985A1 Restin and methods of use thereof
09/27/2000EP1037983A1 Mutants of endostatin, "em 1" having anti-angiogenic activity and methods of use thereof
09/27/2000EP1037915A1 Matrix-remodeling genes
09/27/2000EP1037906A1 Cyclopeptide derivatives with integrin inhibitor properties
09/27/2000EP1037894A1 Pharmaceuticals
09/27/2000EP1037888A1 ($i(E))-3- 1-$i(N)-BUTYL- 5- 2-(2-CARBOXYPHENYL)METHOXY- 4-CHLOROPHENYL]-1$i(H)- PYRAZOL-4-YL]-2- (5- METHOXY-2,3- DIHYDROBENZOFURAN-6-YL)METHYL]- PROP-2-ENOIC ACID MONOARGININYL SALT
09/27/2000EP1037883A1 NOVEL HETEROCYCLICALLY SUBSTITUTED $g(a)-HYDROXYCARBOXLIC ACID DERIVATIVES, METHOD FOR PRODUCING THE SAME AND THEIR USE AS ENDOTHELIN RECEPTOR ANTAGONISTS
09/27/2000EP1037871A1 Novel antiarrhythmic compounds
09/27/2000EP1037670A2 Agent for gene therapy of tumor, neurodegenerative, cardiovascular and autoimmune diseases
09/27/2000EP1037661A1 ribH
09/27/2000EP1037660A1 ribB
09/27/2000EP1037655A2 Methods of treatment using novel ligands of the neuropeptide receptor hfgan72 and agonists or antagonists thereof
09/27/2000EP1037654A1 ribA
09/27/2000EP1037646A1 Ginkgo biloba leaf extracts with a reduced 4'-o-methylpyridoxine and biflavone content
09/27/2000EP1037635A1 Compounds and methods
09/27/2000EP1037628A1 Methods for preventing restenosis using tocotrienols
09/27/2000EP1037623A1 Antihyperlipidemic statin-lp(a) inhibitor combinations
09/27/2000EP1037621A1 Nitric oxide donor compositions, methods, apparatus, and kits for preventing or alleviating vasoconstriction or vasospasm in a mammal
09/27/2000EP1037612A1 Pharmaceutical compositions containing micronized bicyclic drugs
09/27/2000EP0885188B1 Hydroxyamidino derivatives useful as nitric oxide synthase inhibitors
09/27/2000EP0733052B1 Bicyclene derivatives, their production and use
09/27/2000EP0689592B1 Stable bactericidal/permeability-increasing protein products and pharmaceutical compositions containing the same
09/27/2000CN1268175A Catalytic monoclonal antibodies with protease activity for the selective lysis of the protein component of plaques and aggregates related to pathological conditions
09/27/2000CN1268137A Imidazopyrimidines and imidazopyridines for the treatment of neurological disorders
09/27/2000CN1268126A Pyrimidin-2,4,6-trion derivatives and their use as metalloprotease-inhibitors
09/27/2000CN1268122A Branched alkoxy- substituted 2-aminopyridines as NOS inhibitors
09/27/2000CN1268054A Combination therapy comprising amlodipine and a statin compound
09/27/2000CN1268053A Combination therapy comprising atorvastatin and an antihypertensive agent
09/27/2000CN1268052A Therapeutic combinations comprising amlodipin and atorvastatin
09/27/2000CN1267531A Preparation and use of external-use medicine for cardiac and cerebral vascular diseases and rheumatism
09/27/2000CN1056851C Cyclic adhesion inhibitors
09/27/2000CN1056844C Dioxide pyrrolo-pyrrolo derivatives
09/27/2000CN1056837C 5-arylisoxazol-4-yl-substituted 2-aminocarboxylic acid compound, its medical composition and use
09/27/2000CN1056835C Novel selective aromatase inhibiting compounds
09/27/2000CN1056763C Bezoar oral liquid and its producing process
09/26/2000US6124456 Adenosine antagonists
09/26/2000US6124433 Polypeptide for use in the detection and monitoring of atherosclerosis, ischemia, hypertension, restenosis, and arterial inflammation
09/26/2000US6124363 Dofetilide polymorphs
09/26/2000US6124360 Solid compositions suitable for oral administration comprising non hygroscopic salts of L-carnitine and alkanoyl-L-carnitine with 2-aminoethanesulfonic acid
09/26/2000US6124346 Estrogen agonist/antagonists treatment of atherosclerosis
09/26/2000US6124341 Endothelin antagonists
09/26/2000US6124316 Compounds which are specific antagonists of the human NK3 receptor and their use as medicinal products and diagnostic tools
09/26/2000US6124312 Heterocyclic compounds
09/26/2000US6124283 Substituted 1,2,3,4-tetrahydronaphthalene derivatives
09/26/2000US6124281 Azolobenzazepine derivatives as neurologically active agents
09/26/2000US6124264 Growth hormone secretagogue in a human or other animal to treat osteoporosis, congestive heart failure, aging, obesity; bone and wound healing agents
09/26/2000US6124256 Administering an agonist specific for somatostatin (sst) receptor(s) showing an increased expression in the vascular wall subsequent to injury or surgery
09/26/2000US6124131 Protein associated with incresed oxygen demand; for treatment and prevention of tissues damage caused by lack of oxygen
09/26/2000US6124119 Nucleotide sequences coding enzymatic polypeptide; for the treatment and prevention of bacterial infection; bactericides
09/26/2000US6124101 Diagnosis of thrombosis in a mammals; incubating a sample of fluid with an antibody that preferentially binds a cleaved activation peptide, counting antibody bound cleaved activation peptides, compare to control
09/26/2000US6123938 Human urinary hyaluronidase
09/26/2000US6123662 Cardiac disease treatment and device
09/26/2000CA2137832C Inhibitors of angiotensin i chymase(s) including human heart chymase
09/26/2000CA2064108C Thiazolidinone and oxazolidinone derivatives, their preparation and their use as vasodilators
09/21/2000WO2000055371A1 27 human secreted proteins
09/21/2000WO2000055352A2 50 human secreted proteins
09/21/2000WO2000055351A1 Human colon cancer associated gene sequences and polypeptides
09/21/2000WO2000055350A1 Human cancer associated gene sequences and polypeptides
09/21/2000WO2000055332A2 Human regulators of intracellular phosphorylation
09/21/2000WO2000055321A2 Vertebrate protein slit, dna sequence encoding it and uses thereof
09/21/2000WO2000055320A1 Human pancreas and pancreatic cancer associated gene sequences and polypeptides
09/21/2000WO2000055318A2 Abc1 polypeptide and methods and reagents for modulating cholesterol levels
09/21/2000WO2000055201A1 49 human secreted proteins
09/21/2000WO2000055200A1 50 human secreted proteins
09/21/2000WO2000055199A1 47 human secreted proteins
09/21/2000WO2000055183A1 Method for refolding molecules of polypeptides containing ig domains
09/21/2000WO2000055180A2 Human lung cancer associated gene sequences and polypeptides
09/21/2000WO2000055177A2 49 human secreted proteins
09/21/2000WO2000055174A1 Human prostate cancer associated gene sequences and polypeptides
09/21/2000WO2000055173A1 Human breast and ovarian cancer associated gene sequences and polypeptides
09/21/2000WO2000055171A1 50 human secreted proteins
09/21/2000WO2000055159A2 Substituted aza-oxindole derivatives
09/21/2000WO2000055156A1 Substituted aromatic amidine derivative and medicinal composition comprising the same
09/21/2000WO2000055155A2 Heterocyclic compounds as adenosine deaminase inhibitors
09/21/2000WO2000055154A1 Modified amino-acid amides as cgrp antagonists
09/21/2000WO2000055153A1 Amide derivatives
09/21/2000WO2000055152A1 Aromatic heterocyclic compounds as anti-inflammatory agents
09/21/2000WO2000055147A1 Fused 1,4-thiazine-2-carbonitrile derivatives, their preparation and use
09/21/2000WO2000055144A1 Amine derivatives as protease inhibitors
09/21/2000WO2000055139A2 Heterocyclic urea and related compounds useful as anti-inflammatory agents
09/21/2000WO2000055137A1 Compounds and methods for modulation of estrogen receptors
09/21/2000WO2000055127A1 Gamma-ketoacid dipeptides as inhibitors of caspase-3
09/21/2000WO2000055126A2 N-cyanomethylamides as protease inhibitors
09/21/2000WO2000055125A2 N-cyanomethyl amides as protease inhibitors
09/21/2000WO2000055120A1 Amide derivatives
09/21/2000WO2000055114A1 Substituted 2-aminobenzamide caspase inhibitors and the use thereof
09/21/2000WO2000055109A1 Lipoxin compounds and their use
09/21/2000WO2000055072A2 Aerosol metering valve
09/21/2000WO2000054815A2 Expression of dna or proteins in c. elegans
09/21/2000WO2000054806A1 Insulin-like growth factor binding protein-4 protease
1 ... 1262 1263 1264 1265 1266 1267 1268 1269 1270 1271 1272 1273 1274 1275 1276 1277 1278 1279 1280 1281 1282 ... 1595